Gender Differences In Treatment Allocation And Survival In A Real-World Metastatic Pancreatic Cancer Cohort

ANNALS OF ONCOLOGY(2021)

Cited 0|Views5
No score
Abstract
Biological sex and gender has an impact on the incidence rate and outcome in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). The aim of this study is to describe patient characteristics, treatment allocation and overall survival (OS) among men and women with mPDAC in a nationwide cohort.
More
Translated text
Key words
metastatic pancreatic cancer cohort,pancreatic cancer,treatment allocation,gender,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined